Wireless Irradiance SEnsors During Neonatal Phototherapy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

6 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-10

Study Completion Date

2025-09-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Bilisensors are devices designed to measure the cumulative dose of phototherapy administered to neonates undergoing treatment for hyperbilirubinemia. The current standard of care typically involves intermittent spot measurements once a day using a handheld dosimeter that may give variable estimations. In contrast, bilisensors may enable continuous, real-time monitoring of light exposure, helping to know the total phototherapy dose received by the infant.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Transcutaneous Bilirubinometry in Neonates With the Bilicare System

NCT02445755

Transcutaneous Bilirubinometry

COMPLETED

BiliCam Clinical Validation Study

NCT03246503

Newborn Jaundice

COMPLETED

Investigation Into the Dynamic Variations of End-Tidal Carbon Monoxide Concentration (ETCOc) in Neonates Utilizing Non-Dispersive Infrared Spectroscopy and Its Implications for Jaundice Management

NCT07346976

Neonatal Hyperbilirubinemia

RECRUITING NA

The Use of Wireless Sensors in Neonatal Intensive Care

NCT04956354

Preterm Birth Apnea of Newborn

ACTIVE_NOT_RECRUITING

BiLirubin Decrease Under Phototherapy Exposure in the Preterm Newborn in Incubator

NCT03942757

Preterm Infant Jaundice, Neonatal Phototherapy

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neonatal Hyperbilirubinemia Jaundice, Neonatal Phototherapy Complication Newborn Complication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Extremely Preterm Infant

Weighing \< 1500g at recruitment.

No interventions assigned to this group

Late Preterm Infant

Weighing between between 1500g and 2500g at recruitment.

No interventions assigned to this group

Term Infant

Weighing \> 2500g at recruitment.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants must be admitted to the Montreal Children's Hospital (MCH) Neonatal Intensive Care Unit (NICU)
* Under phototherapy as clinically indicated
* Diagnosis of indirect hyperbilirubinemia
* Weight of \>1000g at time of enrollment

Exclusion Criteria

* Any abnormal skin conditions (example: extreme dryness, desquamation, congenital skin disorders, etc.)
* Diagnosis of direct hyperbilirubinemia
* Weight of \<1000g at time of enrollment
* Any baby or family deemed ineligible (ex. too much stress, too unstable) by the clinical care team

Eligible Sex

ALL

Accepts Healthy Volunteers

No